About Wanbury Pharma Limited
Data last updated: 12 February 2026
Wanbury Pharma Limited is a public limited company based in Navi Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 October 2012, the company has been in operation for over 14 years.
Registered with ROC Mumbai under CIN U33119MH2012PLC237381.
Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹5 Lakh. It is led by directors including Vijaykumar Shivaji Ayare and Venkat Kumar Ketha.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: D – 28/11 Midc Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706.
The company is associated with 1 brand - Wanbury Limited.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wanbury.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressD – 28/11 Midc Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Wanbury Pharma Limited
Wanbury Pharma Limited operates one associated brand: Wanbury Limited. These brands represent Wanbury Pharma Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Anti-diabetic drugs and active pharmaceutical ingredients are manufactured. | wanbury.com |
Competitors & Alternatives of Wanbury Pharma Limited
Brands and companies operating in the same space as Wanbury Pharma Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Wanbury Pharma Limited
Wanbury Pharma Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Detailed business activity records for Wanbury Pharma Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Wanbury Pharma Limited
Wanbury Pharma Limited is audited by KAPOOR & PAREKH ASSOCIATES for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KAPOOR & PAREKH ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Wanbury Pharma Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Wanbury Pharma Limited
Wanbury Pharma Limited is currently managed by 3 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Vijaykumar Shivaji Ayare
Also directs:
Parnax Lab Limited
|
Director | 31 Oct 2012 | 13 Years 9 Months | Current |
|
Venkat Kumar Ketha
Also directs:
Expert Chemicals (India) Private Limited, Metallica Enterprise Private Limited, Omkar Logistics Private Limited and 1 more
|
Director | 15 Dec 2022 | 3 Years 7 Months | Current |
|
Sunil Vasudev Kotyankar
Also directs:
Expert Chemicals (India) Private Limited, Bravo Healthcare Limited, Akkadian Trading And Marketing Private Limited and 2 more
|
Director | 15 Dec 2022 | 3 Years 7 Months | Current |
Financials of Wanbury Pharma Limited FY 2025 filings available
Ten-year financial statements for Wanbury Pharma Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Wanbury Pharma Limited
Shareholding and ownership data for Wanbury Pharma Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Wanbury Pharma Limited
Wanbury Pharma Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Wanbury Pharma Limited
View historical data on people associated with Wanbury Pharma Limited, including employment history and EPFO contributions.
Employee and EPFO history for Wanbury Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Wanbury Pharma Limited
GST registrations and filing compliance for Wanbury Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Wanbury Pharma Limited
Credit ratings, litigation, and regulatory alerts for Wanbury Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wanbury Pharma Limited
MSME payment history for Wanbury Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wanbury Pharma Limited
Corporate group structure for Wanbury Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wanbury Pharma Limited
MCA filings and documents for Wanbury Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Wanbury Pharma Limited
Recent News on Wanbury Pharma Limited
Frequently Asked Questions about Wanbury Pharma Limited
Wanbury Pharma Limited is an active public limited company in the pharma sector based in Navi Mumbai, Maharashtra, India. It was incorporated on 31 October 2012 (14+ years old) and is registered under CIN U33119MH2012PLC237381.
The current directors of Wanbury Pharma Limited are:
- Vijaykumar Shivaji Ayare - Director
- Venkat Kumar Ketha - Director
- Sunil Vasudev Kotyankar - Director
The primary industry of Wanbury Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Wanbury Pharma Limited can be reached at the registered office: D – 2811 Midc Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706, or through the website wanbury.com.
The authorised capital is ₹1 Cr, and the paid-up capital is ₹5 Lakh.
The company has its registered office at D – 2811 Midc Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706.